SwePub
Sök i LIBRIS databas

  Utökad sökning

L773:2191 1363
 

Sökning: L773:2191 1363 > Crystal Modificatio...

Crystal Modifications of a Cyclic Guanosine Phosphorothioate Analogue, a Drug Candidate for Retinal Neurodegenerations

Perez, Oswaldo (författare)
RISE,Kemiska processer och läkemedel,Chemical Processes and Pharmaceutical Development, Research Institutes of Sweden, Forskargatan 20 J, 151 36, Södertälje, Sweden, Forskargatan 20 J; Faculty of Pharmaceutical Sciences, University of Iceland, Sæmundargata 2, 102, Reykjavík, Iceland, Sæmundargata 2
Schipper, Nicolaas (författare)
RISE,Kemiska processer och läkemedel,Chemical Processes and Pharmaceutical Development, Research Institutes of Sweden, Forskargatan 20 J, 151 36, Södertälje, Sweden, Forskargatan 20 J
Leandri, Valentina (författare)
RISE,Kemiska processer och läkemedel,Chemical Processes and Pharmaceutical Development, Research Institutes of Sweden, Forskargatan 20 J, 151 36, Södertälje, Sweden, Forskargatan 20 J
visa fler...
Svensson, Per H. (författare)
RISE,KTH,Tillämpad fysikalisk kemi,Chemical Processes and Pharmaceutical Development, Research Institutes of Sweden, Forskargatan 20 J, 151 36, Södertälje, Sweden,Kemiska processer och läkemedel,KTH Royal Institute of Technology, Sweden
Bohlin, Martin (författare)
RISE,Kemiska processer och läkemedel,Chemical Processes and Pharmaceutical Development, Research Institutes of Sweden, Forskargatan 20 J, 151 36, Södertälje, Sweden, Forskargatan 20 J
Loftsson, Thorsteinn (författare)
Faculty of Pharmaceutical Sciences, University of Iceland, Sæmundargata 2, 102, Reykjavík, Iceland, Sæmundargata 2
Bollmark, Martin (författare)
RISE,Kemiska processer och läkemedel,Chemical Processes and Pharmaceutical Development, Research Institutes of Sweden, Forskargatan 20 J, 151 36, Södertälje, Sweden, Forskargatan 20 J
visa färre...
 (creator_code:org_t)
Wiley, 2023
2023
Engelska.
Ingår i: ChemistryOpen. - : Wiley. - 2191-1363. ; 12:12
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • In contribution to the pharmaceutical development of cyclic guanosine monophosphorothioate analogue cGMPSA as a potential active pharmaceutical ingredient (API) for the treatment of inherited retinal degenerations (IRDs), its neutral form (cGMPSA-H) and salts of sodium (-Na), calcium (-Ca), ammonium (-NH4), triethylammonium (-TEA), tris(hydroxymethyl)aminomethane (-Tris), benethamine (-Bnet), and benzathine (-BZ) were prepared. Their solid-state properties were studied with differential scanning calorimetry, thermogravimetric analysis, hot-stage microscopy, and dynamic vapor sorption, and their solubilities were measured in deionized H2O as well as aqueous HCl and NaOH buffers. A total of 21 crystal modifications of cGMPSA were found and characterized by X-ray powder diffraction. Despite their crystalline character, no API forms featured any observable melting points during thermal analyses and instead underwent exothermic decomposition at ≥163 °C. Both the vapor sorption behavior and solubility were found to differ significantly across the API forms. cGMPSA-BZ featured the lowest aqueous solubility and hygroscopicity, with 50 μg/mL and 5 % mass gain at maximum relative humidity. The synthesis and crystallization of some crystal modifications were upscaled to >10 g. Single crystal X-ray diffraction was performed which resulted in the first crystal structure determination and absolute configuration of a cyclic guanosine monophosphorothioate, confirming the RP- conformation at the phosphorus atom.

Ämnesord

NATURVETENSKAP  -- Kemi -- Fysikalisk kemi (hsv//swe)
NATURAL SCIENCES  -- Chemical Sciences -- Physical Chemistry (hsv//eng)
TEKNIK OCH TEKNOLOGIER  -- Medicinteknik (hsv//swe)
ENGINEERING AND TECHNOLOGY  -- Medical Engineering (hsv//eng)

Nyckelord

Configuration determination
Drug design
Neurological agents
Nucleotides
Solid-state structures

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy